US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cocrystal Pharma, Inc.

1.27

+0.03002.42%

Volume:37.59K

Turnover:47.14K

Market Cap:24.46M

PE:-1.67

High:1.27

Open:1.26

Low:1.22

Close:1.24

52wk High:2.67

52wk Low:0.7600

Shares:19.26M

Float Shares:11.85M

Volume Ratio:0.94

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7613

EPS(LYR):-0.7822

ROE:-311.68%

ROA:-96.07%

PB:23.43

PE(LYR):-1.62

Loading ...

Overview Company News Filings

Cocrystal Pharma announces annual shareholder meeting

Cocrystal Pharma Inc - Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus, and Influenza - SEC Filing

THOMSON REUTERS

Cocrystal Pharma announces discovery of pan-viral inhibitors targeting viruses

Cocrystal Pharma reports pan-viral inhibitors showing sub-50 nM potency against hantaan virus in vitro

Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Cocrystal Pharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $225.000K

Benzinga Earnings

Cocrystal Pharma wins FDA Fast Track designation for norovirus drug CDI-988

Cocrystal Pharma Inc expected to post a loss of 15 cents a share - Earnings Preview

Cocrystal Pharma publishes CDI-988 norovirus antiviral presentation slides from ICAR 2026

Cocrystal Pharma advances CDI-988 into Phase 1b norovirus human challenge trial

Cocrystal Pharma files $150M mixed securities shelf

BRIEF-Cocrystal Pharma Inc - Files To Offer Up To $150 Million In Securities - SEC Filing

Cocrystal Pharma Inc - Files to Offer up to $150 Mln in Securities - SEC Filing

THOMSON REUTERS

Cocrystal Pharma publishes investor presentation on antiviral pipeline for norovirus, influenza, coronaviruses

Why Cocrystal Pharma Shares Are Cooling Off Monday?

BUZZ-Cocrystal Pharma rises as FDA fast-tracks oral norovirus drug

Cocrystal Pharma Receives FDA Fast Track Designation for Cdi-988 for Norovirus Infection Treatment and Preventive

THOMSON REUTERS

Cocrystal Pharma starts Phase 1b human challenge trial of norovirus drug CDI-988

Cocrystal Pharma Q4 EPS $(0.17) Beats $(0.21) Estimate

Benzinga Earnings

Cocrystal Pharma 2025 net loss narrows as R&D expenses fall

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/COCP/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"COCP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","market":"US","secType":"STK","nameCN":"Cocrystal Pharma, Inc.","latestPrice":1.27,"timestamp":1789062530685,"preClose":1.24,"halted":0,"volume":37594,"delay":0,"changeRate":0.024193548387096794,"floatShares":11848100,"shares":19263200,"eps":-0.761346,"marketStatus":"Trading","change":0.03,"latestTime":"09-10 13:48:56 EDT","open":1.26,"high":1.273,"low":1.22,"amount":47135.079004399995,"amplitude":0.042742,"askPrice":1.27,"askSize":989,"bidPrice":1.26,"bidSize":1054,"shortable":3,"etf":0,"ttmEps":-0.761346,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.24,"latestTime":"09:26 EDT","volume":860,"amount":1066.473616,"timestamp":1789046808745,"change":0,"changeRate":0,"amplitude":0.02},"postHourTrading":{"tag":"盘后","latestPrice":1.24,"preClose":1.24,"latestTime":"17:18 EDT","volume":20,"amount":24.6,"timestamp":1788988698186,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.93697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"COCP\",,,,,undefined,":{"symbol":"COCP","floatShares":11848100,"roa":"-96.07%","roe":"-311.68%","lyrEps":-0.782196,"volumeRatio":0.93697,"shares":19263200,"dividePrice":0,"high":1.273,"amplitude":0.042742,"preClose":1.24,"low":1.22,"week52Low":0.76,"pbRate":"23.43","psRate":"74.13","week52High":2.67,"institutionHeld":0,"latestPrice":1.27,"committee":0.031816,"eps":-0.761346,"divideRate":0,"volume":37594,"delay":0,"ttmEps":-0.761346,"open":1.26,"prevYearClose":0.979,"prevWeekClose":1.13,"prevMonthClose":1.16,"prevQuarterClose":1.05,"fiveDayClose":1.16,"twentyDayClose":1.12,"sixtyDayClose":0.9901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/COCP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"COCP","fiscalQuarterEnding":"2026/06","expectedEps":-0.17,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2026-05-15","symbol":"COCP","fiscalQuarterEnding":"2026/03","expectedEps":-0.15,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2026-03-31","symbol":"COCP","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"pre","actualEps":-0.17},{"market":"US","date":"2025-11-14","symbol":"COCP","fiscalQuarterEnding":"2025/09","expectedEps":-0.22,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-0.19},{"market":"US","date":"2025-08-14","symbol":"COCP","fiscalQuarterEnding":"2025/06","expectedEps":-0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"COCP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"COCP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1616126400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/COCP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"COCP","date":"2026-09-09","current":-1.641829,"percent":0.202459,"low":-10.090498,"twenty":-2.312515,"median":-1.100367,"eighty":-0.815777,"high":-0.381225,"avg":-1.818023,"sd":1.878386,"marketCap":22730576},"quantilePoints":[{"date":"2021-09-10","current":-9.908687,"twenty":-9.757588,"median":-1.770107,"eighty":-0.744295,"marketCap":106240941},{"date":"2021-09-17","current":-9.545065,"twenty":-9.64851,"median":-1.770107,"eighty":-0.744295,"marketCap":102342192},{"date":"2021-09-24","current":-9.363254,"twenty":-9.602882,"median":-1.770107,"eighty":-0.744295,"marketCap":100392809},{"date":"2021-10-01","current":-9.272349,"twenty":-9.545065,"median":-1.770107,"eighty":-0.744295,"marketCap":99418122},{"date":"2021-10-08","current":-8.636011,"twenty":-9.367688,"median":-1.770107,"eighty":-0.744295,"marketCap":92595312},{"date":"2021-10-15","current":-8.547833,"twenty":-9.333606,"median":-1.770107,"eighty":-0.744295,"marketCap":91649866},{"date":"2021-10-22","current":-8.710554,"twenty":-9.272349,"median":-1.770107,"eighty":-0.744295,"marketCap":93394556},{"date":"2021-10-29","current":-8.110578,"twenty":-9.260106,"median":-1.770107,"eighty":-0.744295,"marketCap":86961620},{"date":"2021-11-05","current":-8.600558,"twenty":-9.171749,"median":-1.770107,"eighty":-0.745161,"marketCap":92215184},{"date":"2021-11-12","current":-8.254209,"twenty":-9.090068,"median":-1.770107,"eighty":-0.745161,"marketCap":88501626},{"date":"2021-11-19","current":-6.664252,"twenty":-8.945494,"median":-1.770107,"eighty":-0.745161,"marketCap":79924371},{"date":"2021-11-26","current":-7.88251,"twenty":-8.908182,"median":-1.770107,"eighty":-0.745161,"marketCap":94534940},{"date":"2021-12-03","current":-5.810903,"twenty":-8.840366,"median":-1.770107,"eighty":-0.745161,"marketCap":69690156},{"date":"2021-12-10","current":-5.851538,"twenty":-8.798268,"median":-1.770107,"eighty":-0.745161,"marketCap":70177499},{"date":"2021-12-17","current":-5.988887,"twenty":-8.660737,"median":-1.770107,"eighty":-0.745161,"marketCap":71824721},{"date":"2021-12-23","current":-5.89705,"twenty":-8.636011,"median":-1.770107,"eighty":-0.745161,"marketCap":70723324},{"date":"2021-12-31","current":-5.282639,"twenty":-8.601301,"median":-1.770107,"eighty":-0.745161,"marketCap":63354689},{"date":"2022-01-07","current":-4.832395,"twenty":-8.551546,"median":-1.770107,"eighty":-0.746027,"marketCap":57954914},{"date":"2022-01-14","current":-4.876282,"twenty":-8.441289,"median":-1.770107,"eighty":-0.746027,"marketCap":58481245},{"date":"2022-01-21","current":-4.307374,"twenty":-8.437358,"median":-1.770107,"eighty":-0.746027,"marketCap":51658338},{"date":"2022-01-28","current":-4.14484,"twenty":-8.3231,"median":-1.770107,"eighty":-0.746027,"marketCap":49709061},{"date":"2022-02-04","current":-4.5195,"twenty":-8.187347,"median":-1.770107,"eighty":-0.746027,"marketCap":54202369},{"date":"2022-02-11","current":-4.509748,"twenty":-8.1073,"median":-1.770107,"eighty":-0.746027,"marketCap":54085406},{"date":"2022-02-18","current":-4.2318,"twenty":-7.87895,"median":-1.770107,"eighty":-0.746027,"marketCap":50751976},{"date":"2022-02-25","current":-4.367523,"twenty":-7.636811,"median":-1.770107,"eighty":-0.746027,"marketCap":52379704},{"date":"2022-03-04","current":-4.146465,"twenty":-7.156757,"median":-1.770107,"eighty":-0.746027,"marketCap":49728555},{"date":"2022-03-11","current":-4.143214,"twenty":-6.788435,"median":-1.770107,"eighty":-0.746027,"marketCap":49689567},{"date":"2022-03-18","current":-4.632468,"twenty":-6.307308,"median":-1.770107,"eighty":-0.746027,"marketCap":55557184},{"date":"2022-03-25","current":-4.067783,"twenty":-5.991813,"median":-1.770107,"eighty":-0.746027,"marketCap":57701496},{"date":"2022-04-01","current":-3.641765,"twenty":-5.818705,"median":-1.770107,"eighty":-0.746027,"marketCap":51658435},{"date":"2022-04-08","current":-3.538696,"twenty":-5.697123,"median":-1.770107,"eighty":-0.746027,"marketCap":50196404},{"date":"2022-04-14","current":-3.676121,"twenty":-5.518362,"median":-1.770107,"eighty":-0.746027,"marketCap":52145779},{"date":"2022-04-22","current":-3.520144,"twenty":-5.42103,"median":-1.770107,"eighty":-0.746027,"marketCap":49933239},{"date":"2022-04-29","current":-3.22949,"twenty":-5.325924,"median":-1.770107,"eighty":-0.746027,"marketCap":45810312},{"date":"2022-05-06","current":-2.923808,"twenty":-5.287882,"median":-1.770107,"eighty":-0.746027,"marketCap":41474221},{"date":"2022-05-13","current":-2.525906,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39543066},{"date":"2022-05-20","current":-2.365897,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":37038120},{"date":"2022-05-27","current":-2.618052,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":40985611},{"date":"2022-06-03","current":-2.720782,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":42593845},{"date":"2022-06-10","current":-2.545207,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":39845219},{"date":"2022-06-17","current":-2.4431,"twenty":-5.283452,"median":-1.770107,"eighty":-0.746027,"marketCap":38246732},{"date":"2022-06-24","current":-2.365897,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":37038120},{"date":"2022-07-01","current":-2.459288,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":38500150},{"date":"2022-07-08","current":-2.60311,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":40751686},{"date":"2022-07-15","current":-2.692142,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":42145489},{"date":"2022-07-22","current":-2.547075,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39874459},{"date":"2022-07-29","current":-2.499751,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39133600},{"date":"2022-08-05","current":-2.521548,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":39474838},{"date":"2022-08-12","current":-2.891376,"twenty":-5.284265,"median":-1.770107,"eighty":-0.745161,"marketCap":45264487},{"date":"2022-08-19","current":-1.131879,"twenty":-5.284265,"median":-1.766483,"eighty":-0.745161,"marketCap":41044193},{"date":"2022-08-26","current":-1.110107,"twenty":-5.284265,"median":-1.756669,"eighty":-0.745161,"marketCap":40254686},{"date":"2022-09-02","current":-1.00716,"twenty":-5.284265,"median":-1.750818,"eighty":-0.745161,"marketCap":36521625},{"date":"2022-09-09","current":-0.968991,"twenty":-5.228721,"median":-1.743495,"eighty":-0.745161,"marketCap":35137566},{"date":"2022-09-16","current":-0.967647,"twenty":-5.13305,"median":-1.739973,"eighty":-0.745161,"marketCap":35088832},{"date":"2022-09-23","current":-0.736756,"twenty":-5.09904,"median":-1.727763,"eighty":-0.74024,"marketCap":26716248},{"date":"2022-09-30","current":-0.782182,"twenty":-5.015848,"median":-1.721316,"eighty":-0.736481,"marketCap":28363474},{"date":"2022-10-07","current":-0.661226,"twenty":-4.934088,"median":-1.717614,"eighty":-0.709858,"marketCap":23977371},{"date":"2022-10-14","current":-0.533102,"twenty":-4.871021,"median":-1.708422,"eighty":-0.608522,"marketCap":19331342},{"date":"2022-10-21","current":-0.499503,"twenty":-4.844354,"median":-1.702965,"eighty":-0.572654,"marketCap":18112980},{"date":"2022-10-28","current":-0.503983,"twenty":-4.837518,"median":-1.692615,"eighty":-0.553005,"marketCap":18275429},{"date":"2022-11-04","current":-0.535342,"twenty":-4.759309,"median":-1.689081,"eighty":-0.549229,"marketCap":19412567},{"date":"2022-11-11","current":-0.678697,"twenty":-4.655621,"median":-1.678549,"eighty":-0.549229,"marketCap":24610911},{"date":"2022-11-18","current":-0.627521,"twenty":-4.629055,"median":-1.678549,"eighty":-0.549229,"marketCap":23858990},{"date":"2022-11-25","current":-0.554703,"twenty":-4.611354,"median":-1.669741,"eighty":-0.549229,"marketCap":21090370},{"date":"2022-12-02","current":-0.586829,"twenty":-4.596503,"median":-1.665114,"eighty":-0.549229,"marketCap":22311820},{"date":"2022-12-09","current":-0.582545,"twenty":-4.592482,"median":-1.658695,"eighty":-0.549229,"marketCap":22148960},{"date":"2022-12-16","current":-0.509727,"twenty":-4.592482,"median":-1.655494,"eighty":-0.543406,"marketCap":19380340},{"date":"2022-12-23","current":-0.421917,"twenty":-4.592482,"median":-1.647648,"eighty":-0.525653,"marketCap":16041710},{"date":"2022-12-30","current":-0.417634,"twenty":-4.592482,"median":-1.638904,"eighty":-0.509727,"marketCap":15878850},{"date":"2023-01-06","current":-0.454043,"twenty":-4.592482,"median":-1.626342,"eighty":-0.498187,"marketCap":17263160},{"date":"2023-01-13","current":-0.458326,"twenty":-4.592482,"median":-1.618166,"eighty":-0.48335,"marketCap":17426020},{"date":"2023-01-20","current":-0.492594,"twenty":-4.592482,"median":-1.617511,"eighty":-0.48335,"marketCap":18728900},{"date":"2023-01-27","current":-0.580404,"twenty":-4.592482,"median":-1.591892,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-03","current":-0.674639,"twenty":-4.592482,"median":-1.591653,"eighty":-0.48335,"marketCap":25650450},{"date":"2023-02-10","current":-0.580404,"twenty":-4.592482,"median":-1.583731,"eighty":-0.48335,"marketCap":22067530},{"date":"2023-02-17","current":-0.477602,"twenty":-4.592482,"median":-1.583731,"eighty":-0.480688,"marketCap":18158890},{"date":"2023-02-24","current":-0.406925,"twenty":-4.592482,"median":-1.583517,"eighty":-0.470748,"marketCap":15471700},{"date":"2023-03-03","current":-0.454043,"twenty":-4.592482,"median":-1.583517,"eighty":-0.460896,"marketCap":17263160},{"date":"2023-03-10","current":-0.417334,"twenty":-4.592482,"median":-1.583517,"eighty":-0.450652,"marketCap":15867449},{"date":"2023-03-17","current":-0.396217,"twenty":-4.592482,"median":-1.569527,"eighty":-0.448315,"marketCap":15064550},{"date":"2023-03-24","current":-0.399429,"twenty":-4.564687,"median":-1.562425,"eighty":-0.444619,"marketCap":15186695},{"date":"2023-03-31","current":-0.417246,"twenty":-4.519825,"median":-1.552061,"eighty":-0.438651,"marketCap":16204570},{"date":"2023-04-06","current":-0.406779,"twenty":-4.509911,"median":-1.541119,"eighty":-0.432034,"marketCap":15798064},{"date":"2023-04-14","current":-0.526296,"twenty":-4.398569,"median":-1.526915,"eighty":-0.430228,"marketCap":20439763},{"date":"2023-04-21","current":-0.620848,"twenty":-4.283651,"median":-1.505609,"eighty":-0.430228,"marketCap":24111882},{"date":"2023-04-28","current":-0.654903,"twenty":-4.151991,"median":-1.491697,"eighty":-0.430228,"marketCap":25434475},{"date":"2023-05-05","current":-0.662762,"twenty":-4.089087,"median":-1.477202,"eighty":-0.430228,"marketCap":25739688},{"date":"2023-05-12","current":-0.705671,"twenty":-4.070648,"median":-1.462998,"eighty":-0.432544,"marketCap":27406155},{"date":"2023-05-19","current":-0.587667,"twenty":-4.070648,"median":-1.462998,"eighty":-0.439616,"marketCap":23399717},{"date":"2023-05-26","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.447562,"marketCap":22687551},{"date":"2023-06-02","current":-0.569781,"twenty":-4.070648,"median":-1.462998,"eighty":-0.449009,"marketCap":22687551},{"date":"2023-06-09","current":-0.674539,"twenty":-4.070648,"median":-1.462998,"eighty":-0.451486,"marketCap":26858805},{"date":"2023-06-16","current":-0.666874,"twenty":-4.070648,"median":-1.462998,"eighty":-0.460896,"marketCap":26553591},{"date":"2023-06-23","current":-0.648989,"twenty":-4.072081,"median":-1.462998,"eighty":-0.470534,"marketCap":25841426},{"date":"2023-06-30","current":-0.628548,"twenty":-4.073513,"median":-1.462998,"eighty":-0.479792,"marketCap":25027523},{"date":"2023-07-07","current":-0.613218,"twenty":-4.074946,"median":-1.466549,"eighty":-0.487594,"marketCap":24417096},{"date":"2023-07-14","current":-0.664319,"twenty":-4.074946,"median":-1.466549,"eighty":-0.496877,"marketCap":26451854},{"date":"2023-07-21","current":-0.697535,"twenty":-4.074946,"median":-1.466549,"eighty":-0.503983,"marketCap":27774446},{"date":"2023-07-28","current":-0.643878,"twenty":-4.074946,"median":-1.466549,"eighty":-0.518294,"marketCap":25637950},{"date":"2023-08-04","current":-0.682205,"twenty":-4.074946,"median":-1.466549,"eighty":-0.526861,"marketCap":27164019},{"date":"2023-08-11","current":-0.753747,"twenty":-4.074946,"median":-1.466549,"eighty":-0.535342,"marketCap":30012680},{"date":"2023-08-18","current":-1.425454,"twenty":-4.074946,"median":-1.480753,"eighty":-0.551021,"marketCap":27876184},{"date":"2023-08-25","current":-1.461871,"twenty":-4.074946,"median":-1.486093,"eighty":-0.554703,"marketCap":28588349},{"date":"2023-09-01","current":-1.560716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.559981,"marketCap":30521370},{"date":"2023-09-08","current":-1.123716,"twenty":-4.074946,"median":-1.497084,"eighty":-0.567553,"marketCap":21975386},{"date":"2023-09-15","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.569781,"marketCap":20754531},{"date":"2023-09-22","current":-1.030073,"twenty":-4.074946,"median":-1.497084,"eighty":-0.577447,"marketCap":20144104},{"date":"2023-09-29","current":-1.014466,"twenty":-4.074946,"median":-1.497084,"eighty":-0.580404,"marketCap":19838890},{"date":"2023-10-06","current":-1.061287,"twenty":-4.074946,"median":-1.497084,"eighty":-0.586829,"marketCap":20754531},{"date":"2023-10-13","current":-0.978049,"twenty":-4.074946,"median":-1.497084,"eighty":-0.591112,"marketCap":19126725},{"date":"2023-10-20","current":-0.874001,"twenty":-4.074946,"median":-1.497084,"eighty":-0.598008,"marketCap":17091967},{"date":"2023-10-27","current":-0.879204,"twenty":-4.074946,"median":-1.498288,"eighty":-0.60429,"marketCap":17193705},{"date":"2023-11-03","current":-0.926025,"twenty":-4.074946,"median":-1.498288,"eighty":-0.611179,"marketCap":18109346},{"date":"2023-11-10","current":-0.93643,"twenty":-4.074946,"median":-1.498288,"eighty":-0.61571,"marketCap":18312822},{"date":"2023-11-17","current":-0.886346,"twenty":-4.074946,"median":-1.498288,"eighty":-0.619712,"marketCap":15972850},{"date":"2023-11-24","current":-0.824246,"twenty":-4.074946,"median":-1.498288,"eighty":-0.625361,"marketCap":14853733},{"date":"2023-12-01","current":-1.072649,"twenty":-4.074946,"median":-1.498288,"eighty":-0.631103,"marketCap":19330201},{"date":"2023-12-08","current":-1.001515,"twenty":-4.074946,"median":-1.4999,"eighty":-0.637045,"marketCap":18048303},{"date":"2023-12-14","current":-1.016193,"twenty":-4.079822,"median":-1.505609,"eighty":-0.642299,"marketCap":18312822},{"date":"2023-12-22","current":-1.067003,"twenty":-4.087137,"median":-1.505609,"eighty":-0.646797,"marketCap":19228463},{"date":"2023-12-29","current":-0.987966,"twenty":-4.088112,"median":-1.505609,"eighty":-0.649529,"marketCap":17804132},{"date":"2024-01-05","current":-1.010548,"twenty":-4.089087,"median":-1.507151,"eighty":-0.654231,"marketCap":18211084},{"date":"2024-01-12","current":-0.959738,"twenty":-4.089087,"median":-1.507151,"eighty":-0.659769,"marketCap":17295443},{"date":"2024-01-19","current":-0.886346,"twenty":-4.090063,"median":-1.501511,"eighty":-0.660576,"marketCap":15972850},{"date":"2024-01-26","current":-0.897638,"twenty":-4.089087,"median":-1.491551,"eighty":-0.660792,"marketCap":16176326},{"date":"2024-02-02","current":-0.92022,"twenty":-4.089087,"median":-1.480753,"eighty":-0.660792,"marketCap":16583277},{"date":"2024-02-09","current":-0.846828,"twenty":-4.089087,"median":-1.46264,"eighty":-0.660792,"marketCap":15260685},{"date":"2024-02-16","current":-0.86941,"twenty":-4.089087,"median":-1.451384,"eighty":-0.660792,"marketCap":15667636},{"date":"2024-02-23","current":-0.8186,"twenty":-4.089087,"median":-1.439402,"eighty":-0.660792,"marketCap":14751995},{"date":"2024-03-01","current":-0.807309,"twenty":-4.088112,"median":-1.429101,"eighty":-0.661009,"marketCap":14548519},{"date":"2024-03-08","current":-0.829891,"twenty":-4.088112,"median":-1.419929,"eighty":-0.661009,"marketCap":14955471},{"date":"2024-03-15","current":-0.829044,"twenty":-4.088112,"median":-1.403373,"eighty":-0.661009,"marketCap":14940210},{"date":"2024-03-22","current":-0.852473,"twenty":-4.088112,"median":-1.369036,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-03-28","current":-0.846828,"twenty":-4.088112,"median":-1.3397,"eighty":-0.661009,"marketCap":15260685},{"date":"2024-04-05","current":-0.831599,"twenty":-4.089087,"median":-1.30291,"eighty":-0.660792,"marketCap":14955471},{"date":"2024-04-12","current":-0.876856,"twenty":-4.089087,"median":-1.294681,"eighty":-0.660792,"marketCap":15769374},{"date":"2024-04-19","current":-0.845742,"twenty":-4.089087,"median":-1.277663,"eighty":-0.660792,"marketCap":15209816},{"date":"2024-04-26","current":-0.854227,"twenty":-4.088112,"median":-1.273457,"eighty":-0.661009,"marketCap":15362422},{"date":"2024-05-03","current":-0.899484,"twenty":-4.088112,"median":-1.227471,"eighty":-0.661009,"marketCap":16176326},{"date":"2024-05-10","current":-0.989998,"twenty":-4.088112,"median":-1.204981,"eighty":-0.661009,"marketCap":17804132},{"date":"2024-05-17","current":-1.193451,"twenty":-4.088112,"median":-1.192088,"eighty":-0.661009,"marketCap":19991497},{"date":"2024-05-24","current":-1.257223,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":21059745},{"date":"2024-05-31","current":-1.433356,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":24010144},{"date":"2024-06-07","current":-1.567035,"twenty":-4.088112,"median":-1.177655,"eighty":-0.661009,"marketCap":26249395},{"date":"2024-06-14","current":-1.585255,"twenty":-4.089087,"median":-1.177345,"eighty":-0.660792,"marketCap":26554609},{"date":"2024-06-21","current":-1.548753,"twenty":-4.090063,"median":-1.177036,"eighty":-0.660576,"marketCap":25943164},{"date":"2024-06-28","current":-1.548753,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":25943164},{"date":"2024-07-05","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-07-12","current":-1.330106,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":22280600},{"date":"2024-07-15","current":-1.396915,"twenty":-4.102253,"median":-1.175733,"eighty":-0.659955,"marketCap":23399717},{"date":"2024-08-02","current":-1.178267,"twenty":-4.144515,"median":-1.153973,"eighty":-0.656828,"marketCap":19737152},{"date":"2024-08-09","current":-1.026429,"twenty":-4.144515,"median":-1.145075,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-08-16","current":-0.970392,"twenty":-4.144515,"median":-1.127576,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-08-23","current":-1.072538,"twenty":-4.144515,"median":-1.122776,"eighty":-0.656828,"marketCap":19228463},{"date":"2024-08-30","current":-0.959042,"twenty":-4.144515,"median":-1.119642,"eighty":-0.656828,"marketCap":17193705},{"date":"2024-09-06","current":-1.01579,"twenty":-4.144515,"median":-1.114787,"eighty":-0.656828,"marketCap":18211084},{"date":"2024-09-13","current":-0.953367,"twenty":-4.144515,"median":-1.108915,"eighty":-0.656828,"marketCap":17091967},{"date":"2024-09-20","current":-0.998766,"twenty":-4.144515,"median":-1.096861,"eighty":-0.656828,"marketCap":17905870},{"date":"2024-09-27","current":-0.970392,"twenty":-4.144515,"median":-1.08975,"eighty":-0.656828,"marketCap":17397180},{"date":"2024-10-04","current":-0.981741,"twenty":-4.144515,"median":-1.088446,"eighty":-0.656828,"marketCap":17600656},{"date":"2024-10-11","current":-0.993091,"twenty":-4.144515,"median":-1.083888,"eighty":-0.656828,"marketCap":17804132},{"date":"2024-10-18","current":-1.15766,"twenty":-4.144515,"median":-1.086013,"eighty":-0.656828,"marketCap":20754531},{"date":"2024-10-25","current":-1.106587,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":19838890},{"date":"2024-10-31","current":-1.02714,"twenty":-4.144515,"median":-1.089629,"eighty":-0.656828,"marketCap":18414559},{"date":"2024-11-08","current":-0.964717,"twenty":-4.14484,"median":-1.089689,"eighty":-0.662762,"marketCap":17295443},{"date":"2024-11-15","current":-1.196788,"twenty":-4.14484,"median":-1.090583,"eighty":-0.665382,"marketCap":22382338},{"date":"2024-11-22","current":-1.169589,"twenty":-4.14484,"median":-1.096861,"eighty":-0.670621,"marketCap":21873648},{"date":"2024-11-29","current":-1.123621,"twenty":-4.14484,"median":-1.107348,"eighty":-0.674539,"marketCap":21013963},{"date":"2024-12-06","current":-1.02271,"twenty":-4.14484,"median":-1.108975,"eighty":-0.679649,"marketCap":19126725},{"date":"2024-12-13","current":-1.01183,"twenty":-4.14484,"median":-1.108975,"eighty":-0.687315,"marketCap":18923249},{"date":"2024-12-20","current":-1.142389,"twenty":-4.14484,"median":-1.110783,"eighty":-0.697513,"marketCap":21364959},{"date":"2024-12-27","current":-1.349107,"twenty":-4.14484,"median":-1.115045,"eighty":-0.705671,"marketCap":25230999},{"date":"2025-01-03","current":-1.262068,"twenty":-4.14484,"median":-1.118187,"eighty":-0.725736,"marketCap":23603192},{"date":"2025-01-10","current":-1.309395,"twenty":-4.145165,"median":-1.120629,"eighty":-0.741734,"marketCap":24488312},{"date":"2025-01-17","current":-1.093429,"twenty":-4.145165,"median":-1.122656,"eighty":-0.761253,"marketCap":20449317},{"date":"2025-01-24","current":-1.133685,"twenty":-4.145165,"median":-1.122776,"eighty":-0.774604,"marketCap":21202178},{"date":"2025-01-31","current":-1.083638,"twenty":-4.145165,"median":-1.122776,"eighty":-0.784117,"marketCap":20266189},{"date":"2025-02-07","current":-1.02815,"twenty":-4.145165,"median":-1.122776,"eighty":-0.795815,"marketCap":19228463},{"date":"2025-02-14","current":-1.01183,"twenty":-4.145165,"median":-1.123621,"eighty":-0.808638,"marketCap":18923249},{"date":"2025-02-21","current":-1.06623,"twenty":-4.145165,"median":-1.123621,"eighty":-0.817765,"marketCap":19940628},{"date":"2025-02-28","current":-0.941111,"twenty":-4.145165,"median":-1.122776,"eighty":-0.818532,"marketCap":17600656},{"date":"2025-03-07","current":-0.957431,"twenty":-4.14549,"median":-1.120629,"eighty":-0.818465,"marketCap":17905870},{"date":"2025-03-14","current":-0.908471,"twenty":-4.14549,"median":-1.11932,"eighty":-0.818465,"marketCap":16990229},{"date":"2025-03-21","current":-0.843192,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":15769374},{"date":"2025-03-28","current":-0.777912,"twenty":-4.14549,"median":-1.11932,"eighty":-0.820967,"marketCap":14548519},{"date":"2025-04-04","current":-0.819529,"twenty":-4.14549,"median":-1.11932,"eighty":-0.824246,"marketCap":14345043},{"date":"2025-04-11","current":-0.712003,"twenty":-4.145165,"median":-1.118997,"eighty":-0.821195,"marketCap":12462892},{"date":"2025-04-17","current":-0.761407,"twenty":-4.145165,"median":-1.118437,"eighty":-0.81871,"marketCap":13327664},{"date":"2025-04-25","current":-0.848591,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14853733},{"date":"2025-05-02","current":-0.918338,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":16074588},{"date":"2025-05-09","current":-0.911479,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":15954537},{"date":"2025-05-16","current":-0.836966,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14650257},{"date":"2025-05-23","current":-0.937203,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":14853733},{"date":"2025-05-30","current":-0.998186,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":15820243},{"date":"2025-06-06","current":-1.04633,"twenty":-4.14549,"median":-1.118717,"eighty":-0.815906,"marketCap":16583277},{"date":"2025-06-13","current":-0.988557,"twenty":-4.14549,"median":-1.117919,"eighty":-0.815906,"marketCap":15667636},{"date":"2025-06-20","current":-0.994976,"twenty":-4.145815,"median":-1.111458,"eighty":-0.815863,"marketCap":15769374},{"date":"2025-06-27","current":-0.994976,"twenty":-4.145815,"median":-1.106587,"eighty":-0.815863,"marketCap":15769374},{"date":"2025-07-03","current":-0.975718,"twenty":-4.145815,"median":-1.097683,"eighty":-0.815863,"marketCap":15464160},{"date":"2025-07-11","current":-1.007814,"twenty":-4.145815,"median":-1.093429,"eighty":-0.815863,"marketCap":15972850},{"date":"2025-07-18","current":-1.084845,"twenty":-4.145815,"median":-1.091415,"eighty":-0.815863,"marketCap":17193705},{"date":"2025-07-25","current":-1.03991,"twenty":-4.145815,"median":-1.088446,"eighty":-0.815863,"marketCap":16481539},{"date":"2025-08-01","current":-1.110522,"twenty":-4.145815,"median":-1.08799,"eighty":-0.815863,"marketCap":17600656},{"date":"2025-08-08","current":-1.059168,"twenty":-4.145815,"median":-1.086013,"eighty":-0.815863,"marketCap":16786753},{"date":"2025-08-15","current":-1.078426,"twenty":-4.145815,"median":-1.083638,"eighty":-0.815863,"marketCap":17091967},{"date":"2025-08-22","current":-1.230721,"twenty":-4.145815,"median":-1.083638,"eighty":-0.815863,"marketCap":15459085},{"date":"2025-08-29","current":-1.282256,"twenty":-4.145815,"median":-1.083638,"eighty":-0.815863,"marketCap":16106419},{"date":"2025-09-05","current":-1.19307,"twenty":-4.14614,"median":-1.083763,"eighty":-0.81582,"marketCap":14986151},{"date":"2025-09-12","current":-1.176082,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":14772767},{"date":"2025-09-19","current":-1.318364,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":16559971},{"date":"2025-09-26","current":-1.297602,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":16299185},{"date":"2025-10-03","current":-1.26646,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":15908004},{"date":"2025-10-10","current":-1.26646,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":15908004},{"date":"2025-10-17","current":-1.110748,"twenty":-4.145815,"median":-1.083888,"eighty":-0.815863,"marketCap":13952102},{"date":"2025-10-24","current":-1.100367,"twenty":-4.145815,"median":-1.087299,"eighty":-0.815863,"marketCap":13821708},{"date":"2025-10-31","current":-1.131509,"twenty":-4.145815,"median":-1.08918,"eighty":-0.815863,"marketCap":14212889},{"date":"2025-11-07","current":-1.048463,"twenty":-4.145815,"median":-1.091415,"eighty":-0.815863,"marketCap":13169741},{"date":"2025-11-14","current":-1.069224,"twenty":-4.145815,"median":-1.097683,"eighty":-0.815863,"marketCap":13430528},{"date":"2025-11-21","current":-1.311275,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":12681339},{"date":"2025-11-28","current":-1.510817,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":14611108},{"date":"2025-12-05","current":-1.475184,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":14266507},{"date":"2025-12-12","current":-1.510817,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":14611108},{"date":"2025-12-19","current":-1.425299,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13784065},{"date":"2025-12-26","current":-1.388384,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13427057},{"date":"2026-01-02","current":-1.395367,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13494599},{"date":"2026-01-09","current":-1.567829,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":15162471},{"date":"2026-01-16","current":-1.582082,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":15300312},{"date":"2026-01-23","current":-1.510817,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":14611108},{"date":"2026-01-30","current":-1.425299,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13784065},{"date":"2026-02-06","current":-1.226042,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":11857052},{"date":"2026-02-13","current":-1.325528,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":12819180},{"date":"2026-02-20","current":-1.396793,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13508383},{"date":"2026-02-27","current":-1.510817,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":14611108},{"date":"2026-03-06","current":-1.425156,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13782686},{"date":"2026-03-13","current":-1.439552,"twenty":-4.145815,"median":-1.100367,"eighty":-0.815863,"marketCap":13921905},{"date":"2026-03-20","current":-1.553576,"twenty":-4.122734,"median":-1.100367,"eighty":-0.815863,"marketCap":15024630},{"date":"2026-03-27","current":-1.468058,"twenty":-4.066422,"median":-1.100367,"eighty":-0.815863,"marketCap":14197586},{"date":"2026-04-02","current":-1.59209,"twenty":-3.983941,"median":-1.100367,"eighty":-0.815863,"marketCap":14059746},{"date":"2026-04-10","current":-2.232322,"twenty":-3.880052,"median":-1.100367,"eighty":-0.815863,"marketCap":19713635},{"date":"2026-04-17","current":-2.450871,"twenty":-3.662379,"median":-1.100367,"eighty":-0.815863,"marketCap":21643641},{"date":"2026-04-24","current":-2.201101,"twenty":-3.583909,"median":-1.100367,"eighty":-0.815863,"marketCap":19437920},{"date":"2026-05-01","current":-2.232322,"twenty":-3.53952,"median":-1.100367,"eighty":-0.815863,"marketCap":19713635},{"date":"2026-05-08","current":-2.169879,"twenty":-3.277451,"median":-1.100367,"eighty":-0.815863,"marketCap":19162205},{"date":"2026-05-15","current":-1.966941,"twenty":-3.225917,"median":-1.100367,"eighty":-0.815863,"marketCap":17370056},{"date":"2026-05-22","current":-1.764619,"twenty":-2.754558,"median":-1.100367,"eighty":-0.815863,"marketCap":15579821},{"date":"2026-05-29","current":-1.764619,"twenty":-2.689901,"median":-1.100367,"eighty":-0.81582,"marketCap":15579821},{"date":"2026-06-05","current":-1.63969,"twenty":-2.644949,"median":-1.100367,"eighty":-0.815863,"marketCap":14476825},{"date":"2026-06-12","current":-1.577226,"twenty":-2.614939,"median":-1.100367,"eighty":-0.815863,"marketCap":13925327},{"date":"2026-06-18","current":-1.516948,"twenty":-2.59128,"median":-1.100367,"eighty":-0.815863,"marketCap":13393131},{"date":"2026-06-26","current":-1.577226,"twenty":-2.552678,"median":-1.100367,"eighty":-0.81582,"marketCap":13925327},{"date":"2026-07-02","current":-1.63969,"twenty":-2.545705,"median":-1.100367,"eighty":-0.81582,"marketCap":14476825},{"date":"2026-07-10","current":-1.577226,"twenty":-2.519431,"median":-1.100367,"eighty":-0.81582,"marketCap":13925327},{"date":"2026-07-17","current":-1.483685,"twenty":-2.506356,"median":-1.100367,"eighty":-0.81582,"marketCap":13099459},{"date":"2026-07-24","current":-1.436837,"twenty":-2.496022,"median":-1.100367,"eighty":-0.81582,"marketCap":12685835},{"date":"2026-07-31","current":-1.355009,"twenty":-2.472985,"median":-1.100367,"eighty":-0.815777,"marketCap":11963372},{"date":"2026-08-07","current":-2.247067,"twenty":-2.439364,"median":-1.100367,"eighty":-0.815777,"marketCap":19839351},{"date":"2026-08-14","current":-2.131984,"twenty":-2.428158,"median":-1.100367,"eighty":-0.815777,"marketCap":21187656},{"date":"2026-08-21","current":-2.267855,"twenty":-2.365897,"median":-1.100367,"eighty":-0.815777,"marketCap":22537944},{"date":"2026-08-28","current":-2.209705,"twenty":-2.357207,"median":-1.100367,"eighty":-0.815777,"marketCap":21960048},{"date":"2026-09-04","current":-2.190322,"twenty":-2.341596,"median":-1.100367,"eighty":-0.815777,"marketCap":21767416},{"date":"2026-09-09","current":-2.287238,"twenty":-2.312515,"median":-1.100367,"eighty":-0.815777,"marketCap":22730576}],"updateTime":1789053622244},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"COCP\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638636177","title":"Cocrystal Pharma announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638636177","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638636177?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:35","pubTimestamp":1779914157,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma will hold its annual shareholder meeting virtually via audio conference call on July 14, 2026.Shareholders will vote to elect five directors for one-year terms.Ballot includes ratification of Weinberg & Company as independent auditor for fiscal 2026.Meeting may also vote on an adjournment to allow additional proxy solicitation if needed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL2Jvzd1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638512832","title":"Cocrystal Pharma Inc - Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus, and Influenza - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638512832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638512832?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:32","pubTimestamp":1779798727,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN4230IO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638951261","title":"Cocrystal Pharma announces discovery of pan-viral inhibitors targeting viruses","url":"https://stock-news.laohu8.com/highlight/detail?id=2638951261","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638951261?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:20","pubTimestamp":1779798021,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (COCP) announces that its novel direct-acting antivirals demonstrate pan-viral activity against multiple viruses, including hantav...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-announces-discovery-of-pan-viral-inhibitors-targeting-viruses-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-announces-discovery-of-pan-viral-inhibitors-targeting-viruses-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638888514","title":"Cocrystal Pharma reports pan-viral inhibitors showing sub-50 nM potency against hantaan virus in vitro","url":"https://stock-news.laohu8.com/highlight/detail?id=2638888514","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638888514?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:01","pubTimestamp":1779796885,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma disclosed early-stage discovery of pan-viral replication inhibitors aimed at hantavirus, bunyavirus, influenza.Results were presented now as initial laboratory findings; broader testing is planned in the future, including work on Andes hantavirus targets.Program showed strong antiviral activity in lab studies, supporting a potential lead candidate for multiple high-unmet-need infections.Move extends its antiviral pipeline beyond CDI-988, which has already entered a Phase 1b norovirus challenge study in the US.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL1YHtnc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","COCP","IE00BGHQF748.EUR","LU2210149790.SGD","BK4585","LU0314104364.USD","IE00BKPKM429.USD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4007","LU2210150020.SGD","NDAQ","SG9999014005.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","BK4588","BK4112","SG9999014021.USD","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635038394","title":"Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635038394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635038394?lang=en_us&edition=fundamental","pubTime":"2026-05-15 22:00","pubTimestamp":1778853610,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc reports results for the quarter ended March 31 - Earnings SummaryCocrystal Pharma Inc COCP.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended March ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL8N41S1JI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635810790","title":"Cocrystal Pharma Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $225.000K","url":"https://stock-news.laohu8.com/highlight/detail?id=2635810790","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635810790?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:09","pubTimestamp":1778846963,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 26.09 percent increase over losses of $(0.23) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52593408/cocrystal-pharma-q1-eps-0-17-misses-0-15-estimate-sales-225-000k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081225","title":"Cocrystal Pharma wins FDA Fast Track designation for norovirus drug CDI-988","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081225","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635081225?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:03","pubTimestamp":1778846598,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma received FDA Fast Track designation for norovirus candidate CDI-988, supporting an accelerated review pathway.NIH awarded an SBIR grant for influenza A and B antiviral lead generation; initial payment totaled USD 225,000.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL6vmbry:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284915","title":"Cocrystal Pharma Inc  expected to post a loss of 15 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284915","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634284915?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:07","pubTimestamp":1778504830,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma Inc  expected to post a loss of15cents a share - Earnings Preview Cocrystal Pharma Inc COCP.OQ COCP.O is expected to  show no change in quarterly revenue when it reports  results on M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O1E3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632661042","title":"Cocrystal Pharma publishes CDI-988 norovirus antiviral presentation slides from ICAR 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2632661042","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632661042?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:01","pubTimestamp":1777582896,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma published a medical research presentation on CDI-988, an oral direct-acting antiviral candidate for norovirus prevention and treatment.Presentation highlighted Phase 1 topline results showing favorable safety and tolerability across 100-1,200 mg dosing.Headache was most frequently reported treatment-emergent adverse event in Phase 1.Update noted FDA Fast Track designation for CDI-988.Phase 1b randomized, double-blind norovirus GII.2 challenge study is enrolling up to 40 healthy adults using 1,200 mg BID dosing on Days 1-5.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cocrystal Pharma Inc. published the original content used to generate this news brief on April 30, 2026, and is solely responsible for the information c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLbFNzzh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632693976","title":"Cocrystal Pharma advances CDI-988 into Phase 1b norovirus human challenge trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2632693976","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632693976?lang=en_us&edition=fundamental","pubTime":"2026-05-01 04:22","pubTimestamp":1777580558,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma highlighted CDI-988 at ICAR 2026, outlining mechanism of action and clinical progress; Phase 1 safety results were already presented.Program moved into ongoing Phase 1b human challenge study designed to show proof of concept for prevention or treatment of norovirus infection.Enrollment completed for first cohort assessing infectivity of GII.2 challenge inoculum, setting up subsequent prevention and treatment cohorts.Company plans to dose CDI-988 at 1,200 mg twice daily for five days in later cohorts, targeting fewer clinical symptoms as primary efficacy outcome.FDA Fast Track designation for CDI-988 supports accelerated development strategy in market with no approved norovirus therapies.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDLx2PF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","COCP","LU2095319765.USD","NDAQ","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2210149790.SGD","LU2210150020.SGD","IE00BGHQF748.EUR","BK4585","LU0314104364.USD","SG9999014005.SGD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629642698","title":"Cocrystal Pharma files $150M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2629642698","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629642698?lang=en_us&edition=fundamental","pubTime":"2026-04-24 07:25","pubTimestamp":1776986720,"startTime":"0","endTime":"0","summary":"19:24 EDT Cocrystal Pharma (COCP) files $150M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cocrystal-pharma-files-150m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629861677","title":"BRIEF-Cocrystal Pharma Inc - Files To Offer Up To $150 Million In Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629861677","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629861677?lang=en_us&edition=fundamental","pubTime":"2026-04-24 06:31","pubTimestamp":1776983486,"startTime":"0","endTime":"0","summary":"BRIEF-Cocrystal Pharma Inc - Files To Offer Up To $150 Million In Securities - SEC FilingApril 23  - Cocrystal Pharma Inc COCP.O:COCRYSTAL PHARMA INC - FILES TO OFFER UP TO $150 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001493152-26-018732]Further company coverage: COCP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41619H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629866880","title":"Cocrystal Pharma Inc - Files to Offer up to $150 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2629866880","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629866880?lang=en_us&edition=fundamental","pubTime":"2026-04-24 05:01","pubTimestamp":1776978061,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN41619H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627232843","title":"Cocrystal Pharma publishes investor presentation on antiviral pipeline for norovirus, influenza, coronaviruses","url":"https://stock-news.laohu8.com/highlight/detail?id=2627232843","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627232843?lang=en_us&edition=fundamental","pubTime":"2026-04-16 02:42","pubTimestamp":1776278569,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma highlighted CDI-988, an oral 3CL protease inhibitor being developed for norovirus infection treatment and prophylaxis, with FDA Fast Track designation.Phase 1 data for CDI-988 showed treatment-emergent adverse events in 28% of treated subjects vs 40% on placebo in single-ascending dose cohorts.Multiple-ascending dose cohorts reported treatment-emergent adverse events in 53% of treated subjects vs 92% on placebo.Company initiated a Phase 1b norovirus human challenge study for CDI-988 at Emory University School of Medicine with up to 40 healthy subjects inoculated with GII.2.Influenza candidate CC-42344 completed an initial Phase 2a challenge study with favorable safety, while efficacy was not reported due to trial conduct and an additional Phase 2a study is planned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDLPG0Nh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625271674","title":"Why Cocrystal Pharma Shares Are Cooling Off Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625271674","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625271674?lang=en_us&edition=fundamental","pubTime":"2026-04-06 21:28","pubTimestamp":1775482080,"startTime":"0","endTime":"0","summary":"Shares of Cocrystal Pharma, Inc.  are trading lower during Monday's pre-market session. The move follows a significant surge during the previous trading day.Nasdaq futures are up 0.43% while S&P 500 futures have gained 0.15%.The biotechnology company experienced a 48.04% rally on Thursday. Many traders are now engaging in profit-taking. This selling pressure has pushed the stock down over 9% before the opening bell.The recent volatility stems from news released Thursday. The U.S. Food and Drug Administration granted Fast Track designation to CDI-988. This is the first oral antiviral candidate for norovirus treatment and prophylaxis.The FDA’s Fast Track program speeds up the review of drugs for serious conditions. It allows for more frequent communication with regulators. It also permits a rolling review of New Drug Applications.Within the 52-week range , the current price sits closer to the lower half of the band, which is consistent with a market that's still rebuilding confidence aft","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/06/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=630","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/06/Candlestick-Graph-Chart-Of-Stock-And-For_0.jpeg?optimize=medium&dpr=2&auto=webp&width=630"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/04/51656980/why-cocrystal-pharma-shares-are-cooling-off-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/04/51656980/why-cocrystal-pharma-shares-are-cooling-off-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624095445","title":"BUZZ-Cocrystal Pharma rises as FDA fast-tracks oral norovirus drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2624095445","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624095445?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:25","pubTimestamp":1775132729,"startTime":"0","endTime":"0","summary":"BUZZ-Cocrystal Pharma rises as FDA fast-tracks oral norovirus drug** Shares of drug developer Cocrystal Pharma COCP.O rise 9% to $1.10 premarket** Co says FDA grants fast-track status to its experimental oral drug CDI-988 for norovirus, a highly contagious stomach virus that causes vomiting and diarrhea; no approved treatments exist** CDI-988 is being tested in an early-stage study in up to 40 healthy adults to reduce norovirus symptoms and assess safety and how the drug moves through the body, co says** Says norovirus hits immunocompromised patients hardest, often causing long-term infections; CDI-988 is not yet approved** Fast-track status aims to speed development and review for drugs addressing serious diseases with unmet medical needs** As of last close, stock up ~4% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nL4N40L10Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591506","title":"Cocrystal Pharma Receives FDA Fast Track Designation for Cdi-988 for Norovirus Infection Treatment and Preventive","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624591506?lang=en_us&edition=fundamental","pubTime":"2026-04-02 20:00","pubTimestamp":1775131203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA50SRCW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624559544","title":"Cocrystal Pharma starts Phase 1b human challenge trial of norovirus drug CDI-988","url":"https://stock-news.laohu8.com/highlight/detail?id=2624559544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624559544?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:30","pubTimestamp":1774996239,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma reported FY 2025 results while starting Phase 1b randomized, double-blind, placebo-controlled human challenge trial of oral norovirus candidate CDI-988 at Emory University School of Medicine.First cohort is underway to confirm infectivity of GII.2 challenge strain, with later cohorts set to receive CDI-988 or placebo.Trial will evaluate whether CDI-988 can lower likelihood of symptomatic illness, with additional readouts on viral shedding, disease severity, safety, pharmacokinetics.Phase 1 safety and tolerability results were already presented in August 2025, supporting continued clinical development.Program targets market with no approved norovirus treatments or vaccines, with global economic burden estimated at USD 60 billion annually.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLc9w6XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623589995","title":"Cocrystal Pharma Q4 EPS $(0.17) Beats $(0.21) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623589995","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623589995?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:14","pubTimestamp":1774959251,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 46.88 percent increase over losses of $(0.32) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51564325/cocrystal-pharma-q4-eps-0-17-beats-0-21-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","COCP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623589516","title":"Cocrystal Pharma 2025 net loss narrows as R&D expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2623589516","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623589516?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:11","pubTimestamp":1774959090,"startTime":"0","endTime":"0","summary":"Cocrystal Pharma 2025 net loss narrows as R&D expenses fallOverviewUS antiviral therapeutics developer's 2025 net loss narrowed yr/yr as R&D expenses declinedCompany enrolled first subjects in Phase 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL1N40J0HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COCP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}